Organ-agnostic automated RECIST measurements across time points with foundation models.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e13669
Abstract: e13669 Background: RECIST 1.1 remains the gold standard for evaluating tumor response in clinical trials and patient care. However, its reliance on manual measurements introduces subjectivity and inter-observer variability, which can affect the accuracy of… read more here.
Keywords: time; time points; recist measurements; recist ... See more keywords